Acute pharmacologic blockade of dyskinesias in Parkinson's disease.
Identifieur interne : 004C05 ( Ncbi/Checkpoint ); précédent : 004C04; suivant : 004C06Acute pharmacologic blockade of dyskinesias in Parkinson's disease.
Auteurs : P J Blanchet [États-Unis] ; L V Metman ; M M Mouradian ; T N ChaseSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1996.
English descriptors
- KwdEn :
- Dextrorphan (administration & dosage), Dextrorphan (therapeutic use), Double-Blind Method, Drug Therapy, Combination, Excitatory Amino Acid Antagonists (administration & dosage), Excitatory Amino Acid Antagonists (therapeutic use), Humans, Levodopa (therapeutic use), Middle Aged, Movement Disorders (complications), Movement Disorders (drug therapy), Parkinson Disease (complications), Placebos, Severity of Illness Index.
- MESH :
- chemical , administration & dosage : Dextrorphan, Excitatory Amino Acid Antagonists.
- chemical , therapeutic use : Dextrorphan, Excitatory Amino Acid Antagonists, Levodopa.
- complications : Movement Disorders, Parkinson Disease.
- drug therapy : Movement Disorders.
- Double-Blind Method, Drug Therapy, Combination, Humans, Middle Aged, Placebos, Severity of Illness Index.
DOI: 10.1002/mds.870110516
PubMed: 8866502
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 004777
- to stream PubMed, to step Curation: 004777
- to stream PubMed, to step Checkpoint: 004882
- to stream Ncbi, to step Merge: 004C05
- to stream Ncbi, to step Curation: 004C05
Links to Exploration step
pubmed:8866502Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acute pharmacologic blockade of dyskinesias in Parkinson's disease.</title><author><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P J" last="Blanchet">P J Blanchet</name><affiliation wicri:level="2"><nlm:affiliation>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Metman, L V" sort="Metman, L V" uniqKey="Metman L" first="L V" last="Metman">L V Metman</name></author><author><name sortKey="Mouradian, M M" sort="Mouradian, M M" uniqKey="Mouradian M" first="M M" last="Mouradian">M M Mouradian</name></author><author><name sortKey="Chase, T N" sort="Chase, T N" uniqKey="Chase T" first="T N" last="Chase">T N Chase</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1996">1996</date><idno type="RBID">pubmed:8866502</idno><idno type="pmid">8866502</idno><idno type="doi">10.1002/mds.870110516</idno><idno type="wicri:Area/PubMed/Corpus">004777</idno><idno type="wicri:Area/PubMed/Curation">004777</idno><idno type="wicri:Area/PubMed/Checkpoint">004882</idno><idno type="wicri:Area/Ncbi/Merge">004C05</idno><idno type="wicri:Area/Ncbi/Curation">004C05</idno><idno type="wicri:Area/Ncbi/Checkpoint">004C05</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Acute pharmacologic blockade of dyskinesias in Parkinson's disease.</title><author><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P J" last="Blanchet">P J Blanchet</name><affiliation wicri:level="2"><nlm:affiliation>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Metman, L V" sort="Metman, L V" uniqKey="Metman L" first="L V" last="Metman">L V Metman</name></author><author><name sortKey="Mouradian, M M" sort="Mouradian, M M" uniqKey="Mouradian M" first="M M" last="Mouradian">M M Mouradian</name></author><author><name sortKey="Chase, T N" sort="Chase, T N" uniqKey="Chase T" first="T N" last="Chase">T N Chase</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="1996" type="published">1996</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dextrorphan (administration & dosage)</term><term>Dextrorphan (therapeutic use)</term><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Excitatory Amino Acid Antagonists (administration & dosage)</term><term>Excitatory Amino Acid Antagonists (therapeutic use)</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Middle Aged</term><term>Movement Disorders (complications)</term><term>Movement Disorders (drug therapy)</term><term>Parkinson Disease (complications)</term><term>Placebos</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dextrorphan</term><term>Excitatory Amino Acid Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dextrorphan</term><term>Excitatory Amino Acid Antagonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Movement Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Movement Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Double-Blind Method</term><term>Drug Therapy, Combination</term><term>Humans</term><term>Middle Aged</term><term>Placebos</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Maryland</li></region></list><tree><noCountry><name sortKey="Chase, T N" sort="Chase, T N" uniqKey="Chase T" first="T N" last="Chase">T N Chase</name><name sortKey="Metman, L V" sort="Metman, L V" uniqKey="Metman L" first="L V" last="Metman">L V Metman</name><name sortKey="Mouradian, M M" sort="Mouradian, M M" uniqKey="Mouradian M" first="M M" last="Mouradian">M M Mouradian</name></noCountry><country name="États-Unis"><region name="Maryland"><name sortKey="Blanchet, P J" sort="Blanchet, P J" uniqKey="Blanchet P" first="P J" last="Blanchet">P J Blanchet</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 004C05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:8866502
|texte= Acute pharmacologic blockade of dyskinesias in Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:8866502" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |